Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Gross Margin (2020 - 2022)

iBio (IBIO) has disclosed Gross Margin for 3 consecutive years, with 105.28% as the latest value for Q1 2022.

  • Quarterly Gross Margin rose 6972.0% to 105.28% in Q1 2022 from the year-ago period, while the trailing twelve-month figure was 115.02% through Jun 2022, up 5711.0% year-over-year, with the annual reading at 115.02% for FY2022, 7668.0% up from the prior year.
  • Gross Margin for Q1 2022 was 105.28% at iBio, down from 203.57% in the prior quarter.
  • The five-year high for Gross Margin was 203.57% in Q3 2021, with the low at 10.42% in Q1 2020.
  • Average Gross Margin over 3 years is 79.25%, with a median of 71.69% recorded in 2020.
  • Peak annual rise in Gross Margin hit 12967bps in 2021, while the deepest fall reached -1139bps in 2021.
  • Over 3 years, Gross Margin stood at 70.07% in 2020, then soared by 191bps to 203.57% in 2021, then plummeted by -48bps to 105.28% in 2022.
  • According to Business Quant data, Gross Margin over the past three periods came in at 105.28%, 203.57%, and 61.91% for Q1 2022, Q3 2021, and Q2 2021 respectively.